<result><Target><Item><Target_ID> 1601</Target_ID>
<Target_Name>Envelope glycoprotein E2</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q06DW6</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Classical swine fever virus:11096</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1602</Target_ID>
<Target_Name>Sera IgG from patients with PMI</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1603</Target_ID>
<Target_Name>Anti-buffalo β-lactoglobulin antibody from rabbit 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1604</Target_ID>
<Target_Name>Anti-buffalo β-lactoglobulin antibody from rabbit 2</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1605</Target_ID>
<Target_Name>β2-glycoprotein I, β2GPI</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1606</Target_ID>
<Target_Name>Monoclonal chimeric IgG anti-β2GPI antibody, HCAL</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1607</Target_ID>
<Target_Name>Low avidity (LAv) IgG anti-β2GPI polyclonal antibody from patient B</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>High avidity (HAv) and low avidity (LAv) IgG anti-β2GPI were isolated from sera of two male patients with primary antiphospholipid syndrome (APS), who suffered initially from venous thrombosis and were positive for IgG anti-β2GPI.</Comments>
</Item><Item><Target_ID> 1608</Target_ID>
<Target_Name>High avidity (HAv) IgG anti-β2GPI polyclonal antibody from patient A</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>High avidity (HAv) and low avidity (LAv) IgG anti-β2GPI were isolated from sera of two male patients with primary antiphospholipid syndrome (APS), who suffered initially from venous thrombosis and were positive for IgG anti-β2GPI.</Comments>
</Item><Item><Target_ID> 1609</Target_ID>
<Target_Name>High avidity (HAv) IgG anti-β2GPI polyclonal antibody from patient B</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>High avidity (HAv) and low avidity (LAv) IgG anti-β2GPI were isolated from sera of two male patients with primary antiphospholipid syndrome (APS), who suffered initially from venous thrombosis and were positive for IgG anti-β2GPI.</Comments>
</Item><Item><Target_ID> 1610</Target_ID>
<Target_Name>Phosphatidylcholine liposome</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1611</Target_ID>
<Target_Name>Endosomal lipid mix, ELM</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1612</Target_ID>
<Target_Name>Silver power</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1613</Target_ID>
<Target_Name>Platinum</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1614</Target_ID>
<Target_Name>Polycrystalline platinum powder</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1615</Target_ID>
<Target_Name>Bone-like mineral film and hydroxyapatite sintered disks</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1616</Target_ID>
<Target_Name>82 nm silica nanoparticles</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1617</Target_ID>
<Target_Name>Germanium thin films on silicon, Ge-on-Si</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The target Ge-on-Si was unannealed and of high defect density.</Comments>
</Item><Item><Target_ID> 1618</Target_ID>
<Target_Name>Squamous cell cancer cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1619</Target_ID>
<Target_Name>Prostate cancer bone metastasis cell</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1620</Target_ID>
<Target_Name>Heart muscle of mdx mouse</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1621</Target_ID>
<Target_Name>Heart muscle and liver of mdx mouse</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1622</Target_ID>
<Target_Name>Quadriceps muscle of mdx mouse</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1623</Target_ID>
<Target_Name>Quadriceps muscle and liver of mdx mouse</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1624</Target_ID>
<Target_Name>Monocytic myeloid-derived suppressor cells, monocytic MDSCs</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1625</Target_ID>
<Target_Name>Envelope glycoprotein E2(661)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P27958 [384-661]</Target_Sequence>
<Synonyms>Envelope glycoprotein E2 alternative name(s):
NS1
gp68
gp70</Synonyms>
<Target_Source>Hepatitis C virus genotype 1a (isolate H) (HCV):11108</Target_Source>
<Target_Structure>1A1R, 1A1V, 1CWX, 1HEI, 1JR6, 1N1L, 1ONB, 1R7C, 1R7D, 1R7E, 1R7F, 1R7G, 1R7Q, 1RGQ, 2A4R, 2F9V, 2HD0, 2JXF, 2KDR, 2O8M, 2OBO, 2OBQ, 2OC0, 2OC1, 2OC7, 2OC8, 2OIN, 2P59, 2XI2, 2XI3</Target_Structure>
<Comments>Full-length E2 protein extends from amino acids 384 to 746 of the HCV polyprotein. The C-terminal truncation of E2 at residue 661 is called E2(661). It has been shown that E2 truncated at residue 661 has a high folding efficiency.</Comments>
</Item></Target></result>